Raynews

Rayner announces first RayOne Galaxy implantations in the US

Posted on 1/10/2024

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, announces today that it has successfully implanted the first lenses in the RayOne Galaxy IOL U.S. Food and Drug Administration (FDA) approved Investigational Device Exemption (IDE) Study.  The study is prospective, multicenter, randomised, masked and active controlled. If successful, the results of

Read more


Rayner closes recruitment for IDE for RayOne EMV Toric IOLs

Posted on 27/06/2024

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the EMV Toric Intraocular lens in the USA. The study reflects Rayner’s continued focus on optimising visual outcomes for surgeons and their patients and

Read more


Rayner marks 5 millionth RayOne lens sold

Posted on 5/04/2024

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s proprietary hydrophilic acrylic material), marking an important milestone in units sold globally. RayOne is Rayner’s fully-preloaded intraocular lens (IOL) injection system, providing smooth, consistent rolling

Read more


Rayner announces packaging updates to reduce environmental impact

Posted on 25/03/2024

Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, is proud to introduce their latest packaging, updated to reduce their carbon footprint, as a contribution to their environmental goals, and to improve ease of use for customers. The new packaging will include: Replacing traditional paper IFU documents with a QR code

Read more


RayOne EMV (Rayner) Receives Health Canada Approval

Posted on 23/01/2024

Mississauga, ON, 23 January 2024 Rayner, a global leader in products for cataract surgery, proudly announces the approval of RayOne EMV (RAO200E) by Health Canada1. Developed in collaboration with Professor Graham Barrett, RayOne EMV is the only patented aspheric IOL that induces controlled positive spherical aberration to slightly extend the depth of focus. “I’ve been awaiting

Read more


Rayner Unveils Exciting Enhancements to Digital Platforms at ESCRS 2023, Booth B303

Posted on 4/09/2023

Worthing, United Kingdom – Rayner, a pioneering leader in ophthalmic innovation, is thrilled to announce a series of ground-breaking updates to its digital platforms, RayPRO and Peer2Peer, set to redefine patient-reported outcome measures (PROMs) and elevate clinical ophthalmic education. Attendees of the ESCRS 2023 congress are invited to explore these transformative advancements at booth B303.

Read more


Rayner Achieves Milestone Implantations in Landmark Clinical Trials in China and the USA

Posted on 11/08/2023

Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two pivotal market access studies in China and the USA. In April, Rayner received approval from the People’s Republic of China’s Ministry of Science and Technology

Read more


Rayner launches ‘Peer2Peer: The Podcast’ for clinical education on the move

Posted on 10/01/2023

The first seven episodes of ‘Peer2Peer: The Podcast’ are now available, featuring Dr Lisa Nijm (USA), Dr Paul Singh (USA), Dr Stefanie Schmickler (Germany), Dr Josefina Botta (Argentina), Dr Karl Stonecipher (USA), Professor Graham Barrett (Australia), Mr Paul Rosen (UK), Mr Allon Barsam (UK), Mr Andrew Turnbull (UK), Dr Eric Donnenfeld (USA) and Dr Jerry

Read more


Rayner announces world’s first implantations of RayOne EMV Toric

Posted on 16/09/2022

16 September 2022. Worthing, United Kingdom – Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced that the world’s first implantations of RayOne EMV Toric had been performed by two highly respected surgeons from the UK. RayOne EMV Toric is the awaited toric variant of Rayner’s popular RayOne

Read more


Rayner to Upgrade RayPRO+ Digital Health Platform at the ESCRS

Posted on 12/09/2022

12th September 2022. Worthing, United Kingdom. Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced the global launch of RayPRO+ at the upcoming ESCRS 2022 congress in Milan. An evolution of RayPRO: Rayner’s proprietary mobile app and web-based digital platform that proactively collects an insightful blend of Patient

Read more